Joseph Vijai

18.7k total citations
62 papers, 976 citations indexed

About

Joseph Vijai is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Joseph Vijai has authored 62 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 20 papers in Cancer Research and 18 papers in Molecular Biology. Recurrent topics in Joseph Vijai's work include Cancer Genomics and Diagnostics (15 papers), BRCA gene mutations in cancer (13 papers) and Genomics and Rare Diseases (9 papers). Joseph Vijai is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), BRCA gene mutations in cancer (13 papers) and Genomics and Rare Diseases (9 papers). Joseph Vijai collaborates with scholars based in United States, India and Canada. Joseph Vijai's co-authors include Kenneth Offit, Mark E. Robson, Zsofia K. Stadler, Kasmintan A. Schrader, Michael F. Walsh, Kurupath Radhakrishnan, Susan M. Domchek, Fergus J. Couch, Katherine L. Nathanson and Moinak Banerjee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Joseph Vijai

54 papers receiving 963 citations

Peers

Countries citing papers authored by Joseph Vijai

Since Specialization

Citations

This map shows the geographic impact of Joseph Vijai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Vijai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Vijai more than expected).

Fields of papers citing papers by Joseph Vijai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Vijai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Vijai. The network helps show where Joseph Vijai may publish in the future.

Co-authorship network of co-authors of Joseph Vijai

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Vijai. A scholar is included among the top collaborators of Joseph Vijai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Vijai. Joseph Vijai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors 2025 ·European Urology Oncology ·(unknown), Yiwen Zhang, Konrad H. Stopsack, Adam S. Kibel, Edward L. Giovannucci, Kathryn L. Penney, Anqi Wang, Joseph Vijai, Philip W. Kantoff, Mark M. Pomerantz, Kenneth Offit, Lorelei A. Mucci, Anna Plym	1
2	BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants 2025 ·Blood Advances ·Paola Ghione, Diana Mandelker, Maria E. Arcila, Venkatraman Seshan, (unknown), Joseph Vijai, (unknown), Chad Vanderbilt, Joyce C. Pressley, Alexander Chan, Natasha Galasso, Ahmet Doǧan, Gilles Salles, Daphne de Jong, Flora E. van Leeuwen, Sarah McCue Horwitz	0
3	Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer 2024 ·Clinical Cancer Research ·Konrad H. Stopsack, Joseph Vijai, (unknown), Jacob E. Berchuck, Yelena Kemel, (unknown), Dory Freeman, Gwo‐Shu Mary Lee, Diana Mandelker, David B. Solit, Michael J. Morris, Kathryn L. Penney, Wassim Abida, Kenneth Offit, Lorelei A. Mucci, Philip W. Kantoff, Mark M. Pomerantz	5
4	CardioCanon: A Customised Chatbot for Cardiology Inquiry With Retrieval Augmented Generation to Reduce Hallucinations and Improve Performance of Large Language Models 2024 ·Heart Lung and Circulation ·Anh Tran, Joseph Vijai, Layton H. Smith, Ashley M. Hopkins, (unknown), Annemarie Hennessy, C. Juergens, H. Dimitri, R. Rajaratnam, (unknown), (unknown), (unknown), (unknown), (unknown), Alan Lee, (unknown), (unknown), (unknown), Kevin Nguyen, Yan Guo	0
5	SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer Death 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Xiaoyu Song, Meng Ru, Zoe Steinsnyder, Kaitlyn Tkachuk, Ryan Kopp, John Sullivan, Zeynep H. Gümüş, Kenneth Offit, Joseph Vijai, Robert J. Klein	3
6	Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing. 2021 ·Journal of Clinical Oncology ·Hong Truong, Kelsey Breen, Yelena Kemel, Andrew T. Lenis, (unknown), Nicole Benfante, Behfar Ehdaie, Karim Touijer, Vincent P. Laudone, Peter T. Scardino, James A. Eastham, Joseph Vijai, Ozge Ceyhan‐Birsoy, Diana Mandelker, Zsofia K. Stadler, Kenneth Offit, Michael J. Morris, Wassim Abida, Mark E. Robson, Maria I. Carlo	0
7	Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes 2019 ·European Journal of Human Genetics ·Mykyta Artomov, Joseph Vijai, Grace Tiao, Tinu Thomas, Kasmintan A. Schrader, Robert J. Klein, Adam Kieżun, Namrata Gupta, Lauren Margolin, Alexander Stratigos, Ivana K. Kim, Kristen Shannon, Leif W. Ellisen, Daniel A. Haber, Gad Getz, Hensin Tsao, Steven M. Lipkin, David Altshuler, Kenneth Offit, Mark J. Daly	4
8	Toward automation of germline variant curation in clinical cancer genetics 2019 ·Genetics in Medicine ·Vignesh Ravichandran, (unknown), Yelena Kemel, Michael F. Walsh, Karen A. Cadoo, Steven M. Lipkin, Diana Mandelker, Liying Zhang, Zsofia K. Stadler, Mark E. Robson, Kenneth Offit, Joseph Vijai	21
9	High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation 2018 ·Human Genetics ·Todd Lencz, Jin Yu, Cameron D. Palmer, Shai Carmi, Danny Ben‐Avraham, Nir Barzilai, Susan Bressman, Ariel Darvasi, Judy H. Cho, Lorraine N. Clark, Zeynep H. Gümüş, Joseph Vijai, Robert J. Klein, Steven M. Lipkin, Kenneth Offit, Harry Ostrer, Laurie J. Ozelius, Inga Peter, Gil Atzmon, Itsik Pe’er	15
10	Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer 2016 ·Clinical Genitourinary Cancer ·Peter H. O’Donnell, Shaheen Alanee, Kelly Stratton, Ilana Garcia-Grossman, Hongyuan Cao, Irina Ostrovnaya, Elizabeth R. Plimack, Christopher Manschreck, (unknown), Norm D. Smith, Gary D. Steinberg, Joseph Vijai, Kenneth Offit, Walter M. Stadler, Dean F. Bajorin	5
11	Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements 2015 ·PLoS ONE ·James E. Hayes, Gosia Trynka, Joseph Vijai, Kenneth Offit, Soumya Raychaudhuri, Robert J. Klein	3
12	An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality 2015 ·British Journal of Cancer ·John Sullivan, Ryan Kopp, Kelly Stratton, Christopher Manschreck, Marina Corines, Rohini Rau‐Murthy, James E. Hayes, (unknown), Asad Ashraf, (unknown), Kasmintan A. Schrader, David Gallagher, Robert J. Hamilton, Howard I. Scher, Hans Lilja, Peter T. Scardino, James A. Eastham, Kenneth Offit, Joseph Vijai, Robert J. Klein	10
13	Variants at IRX4 as prostate cancer expression quantitative trait loci 2013 ·European Journal of Human Genetics ·Xing Xu, (unknown), Joseph Vijai, Kenneth Offit, Mark A. Rubin, Francesca Demichelis, Robert J. Klein	28
14	Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer 2013 ·Familial Cancer ·Shaheen Alanee, Sohela Shah, Joseph Vijai, Kasmintan A. Schrader, Robert J. Hamilton, Rohini Rau‐Murthy, Kara Sarrel, Christopher Manschreck, James A. Eastham, Kenneth Offit	7
15	Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host 2013 ·Annals of Oncology ·David Gallagher, Joseph Vijai, Robert J. Hamilton, Irina Ostrovnaya, Gopa Iyer, Ilana Garcia-Grossman, (unknown), Jennifer A. Przybylo, Shaheen Alanee, Jamie C. Riches, Ashley Marie Regazzi, Mathew I. Milowsky, Kenneth Offit, Dean F. Bajorin	11
16	Genetic architecture of prostate cancer in the Ashkenazi Jewish population 2011 ·British Journal of Cancer ·Joseph Vijai, Tomas Kirchhoff, David Gallagher, Nancy Hamel, Saurav Guha, Ariel Darvasi, Todd Lencz, William D. Foulkes, Kenneth Offit, Robert J. Klein	9
17	A locus for juvenile myoclonic epilepsy maps to 2q33–q36 2010 ·Human Genetics ·Rinki Ratnapriya, Joseph Vijai, (unknown), (unknown), Kurupath Radhakrishnan, Anuranjan Anand	11
18	Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women 2010 ·Breast Cancer Research and Treatment ·Elizabeth Comen, (unknown), Mithat Gönen, Ana Dutra-Clarke, Maurizio Fazio, Joseph Vijai, Zsofia K. Stadler, Noah D. Kauff, Tomas Kirchhoff, Clifford A. Hudis, Kenneth Offit, Mark E. Robson	14
19	The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt 2009 ·Oncogene ·Payaningal R. Somanath, Joseph Vijai, Julia V. Kichina, Tatiana V. Byzova, Eugene Kandel	51
20	Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands 2003 ·Seizure ·Joseph Vijai, Perumpillichira J. Cherian, (unknown), Anuranjan Anand, (unknown)	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact